Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

JUERGENS

Showing results (511-520 of 662) with videos related to

Pageof 67
Sort By:
International Journal of Cardiology|May 7, 2017
The underutilisation of dual antiplatelet therapy in acute coronary syndromeMalcolm Anastasius, Jerrett K Lau, Karice Hyun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancerCharles M Rudin, Ann Mauer, Martin Smakal, et al.
American Heart Journal|March 30, 2013
Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularizationIbrahim M Shugman, Leia Hee, Christian J Mussap, et al.
Cancer Medicine|February 22, 2019
The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing SarcomaLianne M Haveman, Andreas Ranft, Henk Vd Berg, et al.
Cell Reports|May 25, 2022
γδ T cells license immature B cells to produce a broad range of polyreactive antibodiesFrancesca Rampoldi, Elisa Donato, Leon Ullrich, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2014
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in MexicoJuan Carlos Tinoco, Christine Juergens, Guillermo M Ruiz Palacios, et al.
Current Oncology (Toronto, Ont.)|January 5, 2019
Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohortR A Juergens, C Mariano, J Jolivet, et al.
European Heart Journal|December 2, 2022
Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary interventionJaveria Jamal, Hanan Idris, Amir Faour, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 4, 2011
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cellsXiaofang Huo, Stefanie Juergens, Xi Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLCBarbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Pageof 67

Showing results (511-520 of 662) with videos related to

Sort By:
Pageof 67
International Journal of Cardiology|May 7, 2017
The underutilisation of dual antiplatelet therapy in acute coronary syndromeMalcolm Anastasius, Jerrett K Lau, Karice Hyun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2011
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancerCharles M Rudin, Ann Mauer, Martin Smakal, et al.
American Heart Journal|March 30, 2013
Bare-metal stenting of large coronary arteries in ST-elevation myocardial infarction is associated with low rates of target vessel revascularizationIbrahim M Shugman, Leia Hee, Christian J Mussap, et al.
Cancer Medicine|February 22, 2019
The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing SarcomaLianne M Haveman, Andreas Ranft, Henk Vd Berg, et al.
Cell Reports|May 25, 2022
γδ T cells license immature B cells to produce a broad range of polyreactive antibodiesFrancesca Rampoldi, Elisa Donato, Leon Ullrich, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2014
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in MexicoJuan Carlos Tinoco, Christine Juergens, Guillermo M Ruiz Palacios, et al.
Current Oncology (Toronto, Ont.)|January 5, 2019
Real-world benefit of nivolumab in a Canadian non-small-cell lung cancer cohortR A Juergens, C Mariano, J Jolivet, et al.
European Heart Journal|December 2, 2022
Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary interventionJaveria Jamal, Hanan Idris, Amir Faour, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|June 4, 2011
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cellsXiaofang Huo, Stefanie Juergens, Xi Zhang, et al.
Lung Cancer (Amsterdam, Netherlands)|September 18, 2025
Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLCBarbara Melosky, Quincy S C Chu, Rosalyn A Juergens, et al.
Pageof 67